Medylife Healthcare

Strength	100 mg/4 ml
Brand	Bevacirel 100
Active Ingredient	Bevacizumab
Packaging Type	Vial
Shelf Life	24 months
Treatment	Treat Various Cancers

Bevacirel 100mg Injection (bevacizumab) is a targeted cancer therapy used, often with chemotherapy, to inhibit tumor growth by preventing new blood vessel formation. It treats metastatic colorectal, lung, kidney, brain, cervical, and ovarian cancers. It is administered by healthcare professionals via intravenous infusion. 

Strength	400 mg/16 ml
Brand	Bevatas 400 mg
Manufacturer	Intas Pharmaceuticals
Active Ingredient	Bevacizumab
Volume	16 ml
Packaging Type	Vial
Treatment	Treatment of Cancer

Bevatas 400mg Injection (Bevacizumab) is an anti-angiogenic, anti-cancer medication that inhibits tumor blood supply, slowing growth. It is used alongside chemotherapy for metastatic colorectal, non-small cell lung, kidney, brain, cervical, and ovarian cancers. It is administered by healthcare professionals via IV infusion, not self-injected. 

Strength	100 mg/4 ml
Brand	Bevatas 100 mg
Manufacturer	Intas Pharmaceuticals
Active Ingredient	Bevacizumab
Volume	4 ml
Packaging Type	Vial
Shelf Life	24 months
Treatment	Targeted Cancer Therapy

Bevatas 100mg Injection (Bevacizumab) is a targeted cancer therapy used to treat various cancers, including colorectal, lung, brain (glioblastoma), kidney, cervical, and ovarian cancers, by inhibiting the growth of blood vessels that supply tumors. It is administered via intravenous infusion by a healthcare professional, often in combination with chemotherapy. 

Strength	400 mg/16 ml
Brand	Bevacirel 400
Manufacturer	Relience
Active Ingredient	Bevacizumab
Pharmaceutical Form	Concentrate
Volume	16 ml
Packaging Type	Vial
Shelf Life	24 months
Treatment	Targeted Cancer Therapy

Bevacirel 400mg Injection (Bevacizumab) is a vascular endothelial growth factor (VEGF) inhibitor used to treat various cancers, including metastatic colorectal, non-small cell lung, kidney, cervical, ovarian, and brain (glioblastoma) cancers. It works by cutting off the blood supply needed for tumor growth. 

Strength

300mg/12ml

Bryxta 300mg Injection (Bevacizumab) is a targeted cancer therapy used to treat various advanced cancers, including metastatic colorectal, lung, kidney, cervical, and ovarian cancer, as well as glioblastoma. It works by inhibiting VEGF, starving tumors of oxygen and nutrients. It is administered via intravenous infusion by healthcare professionals. 

Strength	300 mg/4 ml
Brand	Bevatas 300
Packaging Type	Vial

Bevatas 300mg Injection (bevacizumab) is a targeted cancer therapy (monoclonal antibody) used to treat various advanced cancers, including colorectal, lung, ovarian, cervical, kidney, and brain tumors. It works by inhibiting angiogenesis—blocking new blood vessel growth to tumors. It is administered by a healthcare professional via intravenous infusion.